Key result
Epiisopiloturine pretreatment reduces AV block by ~63% and lowers lethality during ischemia-reperfusion in rats.
Why the study?
Given that epiisopiloturine demonstrated anti-inflammatory and antioxidant effects in mice models, the authors investigated its potential cardioprotective activity in an animal model of cardiac ischemia/reperfusion.
Does epiisopiloturine pretreatment reduce arrhythmias and lethality in rats submitted to cardiac ischemia and reperfusion?
Does epiisopiloturine pretreatment reduce arrhythmias and lethality in rats submitted to cardiac ischemia and reperfusion?
Absolute Event Rate: 30% vs 80%
Epiisopiloturine pretreatment demonstrates cardioprotective effects by reducing severe arrhythmias and lethality in a rat model of ischemia-reperfusion injury.
Reduces AV block and lethality in rat ischemia-reperfusion; hypothesis-generating and requires human trials before clinical consideration.
Acute myocardial infarction (AMI), which is characterized by severe and fatal arrhythmias resultant from cardiac ischemia/reperfusion (CIR), is the leading cause of morbidity and mortality in the world. Considering that epiisopiloturin (EPI), an imidazole alkaloid found in the leaves of Pilocarpus microphyllus produded anti-inflammatory and antioxidant effects in an animal model of peritonitis, paw edema and peritonitis in mice, we decided to investigate the potential cardioprotective activity of EPI in animal model of CIR. Then, adult rats submitted to CIR pretreated with EPI 10 mg/kg (EPI10+CIR group) or 15 mg/kg (EPI15+CIR group) were compared to control animals submitted to CIR treated with saline solution 0.9% (CIR group). To evaluate the incidence of ventricular arrhythmias (VA), atrioventricular block (AVB) and lethality (LET) induced by CIR in these rats, the ECG analysis was performed. Serum levels of cardiac damage markers, total creatine kinase (CK) and CK-MB, were measured. The results showed that the AVB incidence was reduced from 80% to 30%, and LET incidence was reduced from 70% to 20%, compared to CIR group. Serum levels of LDH, total CK and, CK-MB was similar in all groups studied. These results indicate that the treatment with EPI (15 mg/kg, IV) before CIR was effective to produce cardioprotective effects. Thus, the use of EPI could be a promisse strategy to reduce the incidence of severe and fatal arrhythmias associated with AMI.
No takes yet. Share an insight, caveat, or question.
Moraes et al. (2023) studied Cardiac ischemia and reperfusion. Epiisopiloturine (EPI) vs. Saline solution 0.9% was evaluated on Incidence of atrioventricular block (AVB). Pretreatment with epiisopiloturine (15 mg/kg, IV) before cardiac ischemia and reperfusion in rats reduced the incidence of atrioventricular block from 80% to 30% and lethality from 70% to 20%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: